SEDN yields 2000000.00% · JNJ yields 2.13%● Live data
📍 SEDN pulled ahead of the other in Year 1
Combined, SEDN + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SEDN + JNJ for your $10,000?
SED International Holdings, Inc., together with its subsidiaries, distributes information technology (IT) products and solutions, computer systems, and mobility devices in the United States, Latin America, and the Caribbean. The company primarily offers complete notebook and desktop systems, peripherals and accessories, and components, as well as software and related services. It also provides fulfillment services to e-commerce customers and other resellers; IT product procurement services; and system integration and configuration services. The company sells its products through a sales force and Website to reseller customers in retail, e-commerce, value added resellers, system builders, original equipment manufacturers, and various other reseller channels. SED International Holdings, Inc. was founded in 1980 and is based in Lawrenceville, Georgia. On February 24, 2018, an involuntary petition for liquidation under Chapter 7 was filed against SED International Holdings, Inc. in the U.S. Bankruptcy Court for the Northern District of Georgia. On September 13, 2016, the involuntary petition was approved by the Court and the Chapter 7 petition was converted to Chapter 11 reorganization. The plan was later approved as Chapter 11 liquidation on June 20, 2018.
Full SEDN Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.